[NT 10-K] Ameritek Ventures, Inc. SEC Filing

Rhea-AI Filing Summary

Ameritek Ventures, Inc. filed a Form 12b-25 notifying the SEC that its Form 10-K for the period ended December 31, 2025 could not be filed on time because additional time is required to finalize the financial statements. The company states the annual report "will be filed on or before the fifteenth calendar day following the prescribed due date." The notification names Shaun Passley, Ph.D. as the contact and affirms that other periodic reports for the prior 12 months have been filed. The filing also states that no significant change in results of operations is anticipated to be reflected in the delayed report.

Key Figures

Period end: December 31, 2025 Cure period: 15 calendar days Contact phone: 312-285-1043 +1 more

4 metrics

Period end December 31, 2025 Form 10-K period to be filed

Cure period 15 calendar days filing will be made on or before the fifteenth calendar day following the prescribed due date

Contact phone 312-285-1043 Contact for this notification: Shaun Passley, Ph.D.

Registrant address ZIP 60090 Ameritek Ventures principal executive office, Wheeling, IL

Key Terms

Rule 12b-25, Form 10-K, prescribed due date

3 terms

Rule 12b-25 regulatory

"Form 12b-25 notification and references to Rule 12b-25(b) and (c)"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-K regulatory

"The company is unable to file its Form 10-K report for the period ending December 31, 2025"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

prescribed due date regulatory

""on or before the fifteenth calendar day following the prescribed due date""

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

Comission File Number:

(Check One)      ☒  Form 10-K        ☐  Form 20-F        ☐  Form 11-K        ☐  Form 10-Q        ☐  Form 10-D        ☐  Form N-SAR        ☐  Form N-CSR

For Period Ended:      December 31, 2025

☐  Transition Report on Form 10-K

☐  Transition Report on Form 20-F

☐  Transition Report on Form 11-K

☐  Transition Report on Form 10-Q

For the Transition Period Ended:     

________________________________________________

READ INSTRUCTION (on back page) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

___________________________________________________

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Ameritek Ventures, Inc.

Full Name of Registrant

Former Name if applicable

325 N Milwaukee Ave. Suite G1

Address of Principal Executive Office (Street and Number)

Wheeling, IL 60090

City, State and Zip Code

PART II — RULES 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

x (a)The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; 

x (b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and 

o (c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable 

PART III — NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Company is unable to file its Form 10-K report for the period ending December 31, 2025 within the prescribed time period because additional time is required to finalize its financial statements that are to be filed as part of the report.

PART IV — OTHER INFORMATION

(1)Name and telephone number of person to contact in regard to this notification 

Shaun Passley, Ph.D.		312-285-1043
(Name)		(Telephone Number)

(2)Have all other periodic reports required under Section 13 or 15(d) or the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  

If answer is no identify report(s)

Yes x No o

__________________________________________________________________________________________ 

(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 

Yes o No x

___________________________________________________________________________________________

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made:

     Ameritek Ventures, Inc.     

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:     March 31, 2026    By:/s/ Shaun Passley, Ph.D.       Name:Shaun Passley, Ph.D.  Title:Chief Executive Officer, CFO, Chairman 

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the persons signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

GENERAL INSTRUCTION

1.This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934. 

2.One signed original and four conformed copies of this form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington, D.C. 20549 in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed with the form will be made a matter of public record in the Commission files. 

3.A manually signed copy of the form and amendments thereto shall be filed with each national securities exchange on which any class of securities of the registrant is registered. 

4.Amendments to the notifications must also be filed on form 12b-25 but need not restate information that has been correctly furnished. The form shall be clearly identified as an amendment notification. 

5.ELECTRONIC FILERS. This form shall not be used by electronic filers unable to timely file a report solely due to electronic difficulties. Filers unable to submit a report within the time period prescribed due to difficulties in electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T (Section 232.201 or Section 232.202 of this chapter) or apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T (Section 232.12(c) of this chapter).